subject: CHEBI:27732

subject_name: Caffeine

object_name: migraine


subject: CHEBI:27732

object_name: migraine with or without aura, susceptibility to, 1

tested_intervention: yes


subject: CHEBI:27732

object_name: Acute migraine


subject: UMLS:C0251564

subject_name: Pulmozyme

object_name: sinusitis

tested_intervention: unsure


subject: UMLS:C0251564

object_name: Sinusitis, CTCAE


subject: UNII:953A26OA1Y

subject_name: Dornase alfa


subject: UNII:953A26OA1Y


subject: PR:000006592


subject: PR:000006592


subject: PR:000006592

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:2269

object_name: pharyngitis


subject: PUBCHEM.COMPOUND:2269

object_name: Pharyngitis, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: tonsillitis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:64816

object_name: fallopian tube carcinoma


subject: CHEBI:64816

object_name: fallopian tube cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:81045

subject_name: lead oxide

object_name: hypertension


subject: CHEBI:81045

object_name: Hypertension, CTCAE


subject: CHEBI:53450

subject_name: poly(butylene oxide) macromolecule


subject: CHEBI:53450


subject: CHEBI:61603

subject_name: poly(butylene oxide) polymer


subject: CHEBI:61603


subject: CHEBI:32687

subject_name: Piperonyl butoxide


subject: CHEBI:32687


subject: UMLS:C3526551

subject_name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus (DTaP-IPV) Vaccine

object_name: tetanus


subject: UMLS:C3526551

object_name: pertussis


subject: UMLS:C3526551

object_name: diphtheria


subject: UMLS:C3526551

object_name: poliomyelitis


subject: UMLS:C3526551

object_name: bacterial meningitis


subject: CHEBI:51352

subject_name: Bicillin L-A

object_name: rheumatic heart disease


subject: PUBCHEM.COMPOUND:9985566


subject: CHEBI:17334

subject_name: penicillin


subject: UMLS:C2348335

subject_name: Doxorubicin-GNRH Agonist Conjugate AEZS-108

object_name: hormone-resistant prostate carcinoma


subject: UMLS:C2348335

object_name: prostate carcinoma


subject: UMLS:C2348335

object_name: prostate cancer


subject: UMLS:C2348335

object_name: Prostate cancer recurrent


subject: UMLS:C2348335

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C2348335

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C2348335

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C2348335

object_name: Stage IV Prostate Cancer AJCC v8


subject: MESH:C000730795

object_name: Mechanical ventilation finding


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist


subject: UMLS:C1518041


subject: UMLS:C4721408

subject_name: Substance with receptor antagonist mechanism of action (substance)


subject: UMLS:C4721408


subject: UMLS:C4548529

subject_name: DTaP-IPV-HB-PRP-T vaccine

object_name: hepatitis B


subject: UMLS:C4548529


subject: UMLS:C4548529


subject: UMLS:C4548529


subject: UMLS:C4725106

subject_name: PI3K-d Inhibitor HMPL 689

object_name: follicular lymphoma


subject: UMLS:C4725106

object_name: marginal zone lymphoma


subject: UMLS:C4725106

object_name: MALT lymphoma


subject: UMLS:C0041044

object_name: pyelonephritis


subject: UNII:VR034VW8OG

subject_name: Enecadin

object_name: stroke disorder


subject: UNII:VR034VW8OG

object_name: cerebrovascular disorder


subject: UNII:VR034VW8OG

object_name: Stroke (heart beat)


subject: UNII:VR034VW8OG

object_name: Stroke, CTCAE


subject: CHEBI:6710

subject_name: Meclofenamic acid

object_name: psychosis


subject: CHEBI:6710

object_name: bipolar disorder


subject: CHEBI:6710

object_name: schizoaffective disorder


subject: CHEBI:6710

object_name: schizophrenia 18


subject: CHEBI:6710

object_name: schizophrenia


subject: UNII:914032762Y

subject_name: PENTOSAN POLYSULFATE SODIUM


subject: UNII:914032762Y


subject: UNII:914032762Y


subject: UNII:914032762Y


subject: UNII:914032762Y


subject: CHEBI:184555

subject_name: Xylan Sulfate


subject: CHEBI:184555


subject: CHEBI:184555


subject: CHEBI:184555


subject: CHEBI:184555


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: paranasal sinus carcinoma


subject: CHEBI:72317

object_name: paranasal sinus squamous cell carcinoma


subject: CHEBI:72317

object_name: Head and neck cancer metastatic


subject: CHEBI:72317

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:72317

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: CHEBI:72317

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:72317

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:72317

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:72317

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: CHEBI:72317

object_name: Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:72317

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:72317

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: paranasal sinus carcinoma


subject: UNII:DPT0O3T46P

object_name: paranasal sinus squamous cell carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Pattern dystrophy of macula


subject: UNII:T6A6936CNW

object_name: plasma cell myeloma


subject: UMLS:C5555851


subject: UMLS:C4733645

object_name: cancer


subject: UMLS:C4733645

object_name: neoplasm


subject: CHEBI:135919

subject_name: Nesiritide

object_name: pulmonary hypertension


subject: CHEBI:135919

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:135919

object_name: lung disorder


subject: CHEBI:135919


subject: CHEBI:135919


subject: PUBCHEM.COMPOUND:53395955

subject_name: Natrecor


subject: PUBCHEM.COMPOUND:53395955


subject: PUBCHEM.COMPOUND:53395955


subject: PUBCHEM.COMPOUND:53395955


subject: PUBCHEM.COMPOUND:53395955


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: GTOPDB:12990

subject_name: sintilimab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:12990

object_name: clear cell renal carcinoma


subject: GTOPDB:12990

object_name: renal cell adenocarcinoma


subject: GTOPDB:12990

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:2735

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:2735

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:Y333RS1786

subject_name: Cenerimod

object_name: Hepatic impairment


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Congenital absence of uterus


subject: CHEBI:61057

object_name: female infertility


subject: CHEBI:61057

object_name: Mayer-Rokitansky-Kuster-Hauser syndrome


subject: CHEBI:61057

object_name: mullerian aplasia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: ovarian cancer


subject: UNII:53O87HA2QU

object_name: ovarian neoplasm


subject: UNII:53O87HA2QU

object_name: ovarian carcinoma


subject: CHEBI:173763

subject_name: Thermophillin

object_name: type 2 diabetes mellitus


subject: CHEBI:73659

subject_name: Thr-Thr-Asp


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:140779


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Intertrochanteric Fractures


subject: UMLS:C3827136

object_name: non-small cell lung carcinoma


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Locally advanced breast cancer


subject: UNII:46D4HS9ODA

subject_name: Samuraciclib


subject: UNII:46D4HS9ODA

object_name: Carcinoma breast stage IV


subject: MESH:C551853

subject_name: Viusid


subject: MESH:C551853

object_name: Coronavinae infectious disease


subject: MESH:C551853

object_name: COVID-19 respiratory infection


subject: MESH:C551853

object_name: viral disease


subject: MESH:C551853

object_name: respiratory tract infectious disorder


subject: MESH:C551853

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: cardiovascular disorder


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat

object_name: Childhood Neuroblastoma


subject: UNII:3S9RX35S5X

object_name: neuroblastoma


subject: UNII:3S9RX35S5X

object_name: adult lymphoma


subject: UNII:3S9RX35S5X

object_name: lymphoma


subject: UNII:3S9RX35S5X

object_name: pediatric lymphoma


subject: UNII:3S9RX35S5X

object_name: brain neoplasm


subject: UNII:3S9RX35S5X

object_name: Childhood Solid Neoplasm


subject: UNII:3S9RX35S5X

object_name: Adult Solid Neoplasm


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: kidney disorder


subject: UMLS:C0013227

object_name: impaired renal function disease


subject: UMLS:C0013227


subject: UMLS:C0013227

object_name: myocardial ischemia


subject: UMLS:C0013227

object_name: coronary atherosclerosis


subject: UMLS:C0013227

object_name: heart disorder


subject: UMLS:C0013227

object_name: End stage renal failure on dialysis


subject: UMLS:C1615615

subject_name: Mexoryl XL

object_name: Solar elastosis


subject: CHEBI:135830

subject_name: Ecamsule


subject: UMLS:C0169691

subject_name: Mexoryl SX


subject: CHEBI:6801

subject_name: Metformin

object_name: Overweight


subject: CHEBI:6801

object_name: Elevated circulating hepatic transaminase concentration


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907


subject: GTOPDB:12312

subject_name: inclacumab

object_name: Vaso-Occlusive Crisis


subject: GTOPDB:12312

object_name: sickle cell disease


subject: GTOPDB:12312

object_name: Vaso-occlusive pain episode in sickle cell disease


subject: UNII:A6734I702L


subject: UNII:A6734I702L


subject: UNII:A6734I702L


subject: UMLS:C4078374


subject: UMLS:C4078374


subject: UMLS:C4078374


subject: PUBCHEM.COMPOUND:122706909

subject_name: Vadastuximab Talirine

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:122706909

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:122706909

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:122706909

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:T13V17U431

subject_name: vadastuximab talirine


subject: UNII:T13V17U431


subject: UNII:T13V17U431


subject: UNII:T13V17U431


subject: UMLS:C3827077


subject: UMLS:C3827077


subject: UMLS:C3827077


subject: UMLS:C3827077


subject: CHEBI:6754

subject_name: Meperidine

object_name: Postoperative Pain, Acute


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: neoplastic meningitis


subject: UMLS:C3896780

object_name: prostate carcinoma


subject: UMLS:C3896780

object_name: prostate cancer


subject: UMLS:C5540119

subject_name: Piflufolastat F 18 Intravenous Solution [PYLARIFY]


subject: UMLS:C5540119


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Mood Alteration


subject: CHEBI:4806

subject_name: Epigallocatechin gallate


subject: CHEBI:51098

subject_name: Motesanib

object_name: Advanced Gastrointestinal Stromal Tumor


subject: UMLS:C1541476

subject_name: AMG 706


subject: CHEBI:94686

subject_name: Orlistat

object_name: urate measurement


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: lymphangioleiomyomatosis


subject: CHEBI:60648

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:60648

object_name: tuberous sclerosis


subject: CHEBI:60648

object_name: situs inversus


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:83629

subject_name: tea tree oil

object_name: Periodontal Pocket


subject: DRUGBANK:DB11218

subject_name: Tea tree oil


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: chronic kidney disease


subject: CHEBI:135930

subject_name: Lercanidipine


subject: CHEMBL.COMPOUND:CHEMBL4297257

subject_name: ALBUVIRTIDE

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL4297257

object_name: AIDS


subject: UMLS:C3493164

subject_name: albuvirtide


subject: UMLS:C3493164


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Body Composition


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEBI:7025

subject_name: Mupirocin

object_name: Cross Infection


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: venous thromboembolism


subject: CHEBI:94518

object_name: thrombophilia due to thrombin defect


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Advanced Cholangiocarcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: hypertension


subject: CHEBI:84094

object_name: Hypertension, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: Pruritus, CTCAE


subject: CHEBI:59773

object_name: Pruritus


subject: CHEBI:59773

object_name: end stage renal failure


subject: CHEBI:59773

object_name: Chronic uremia


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Spasticity


subject: UNII:UC95NQ339C

object_name: stroke disorder


subject: UNII:UC95NQ339C

object_name: cerebrovascular disorder


subject: UNII:UC95NQ339C

object_name: Stroke (heart beat)


subject: UNII:UC95NQ339C

object_name: Stroke, CTCAE


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UNII:71M78END5S

object_name: sarcopenia


subject: CHEBI:25681


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Pulmonary artery pressure


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: gastric adenocarcinoma


subject: UNII:KXG2PJ551I

object_name: esophageal adenocarcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C1567931

subject_name: Macugen

object_name: diabetic macular edema


subject: UNII:3HP012Q0FH


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: MESH:C438506

subject_name: HLA-A*24:02 antigen

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:2008

subject_name: Aclacinomycin A zwitterion

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:2008

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:2008

object_name: Leukaemia recurrent


subject: CHEBI:74619

subject_name: Aclarubicin


subject: CHEBI:567361

subject_name: Cladribine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:76013112

subject_name: SELEPRESSIN

object_name: septic shock


subject: UMLS:C4519663

subject_name: Selepressin


subject: CHEBI:16382

subject_name: Iodide

object_name: thyroid tumor


subject: CHEBI:16382

object_name: thyroid gland carcinoma


subject: CHEBI:16382

object_name: thyroid cancer


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: CHEBI:132922

object_name: bariatric surgery candidate


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C5235019

subject_name: Aerius

object_name: Allergic rhinoconjunctivitis


subject: CHEBI:291342

subject_name: Desloratadine


subject: UMLS:C4745033

subject_name: Carbon C 11-osimertinib

object_name: non-small cell lung carcinoma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: idiopathic dilated cardiomyopathy


subject: CHEBI:3441

object_name: familial dilated cardiomyopathy


subject: CHEBI:3441

object_name: dilated cardiomyopathy 1A


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:4708

subject_name: Doxazosin


subject: CHEBI:4708


subject: CHEBI:4708


subject: UMLS:C1874451

subject_name: Basis

object_name: acute kidney failure


subject: UMLS:C1874451

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:4453

subject_name: Desogestrel

object_name: central hypoventilation syndrome, congenital


subject: CHEBI:4453

object_name: central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease


subject: UMLS:C0021761

object_name: castration-resistant prostate carcinoma


subject: UMLS:C0021761

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C0021761

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C0021761

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C0021761

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C0021761

object_name: metastatic prostate carcinoma


subject: UMLS:C0021761

object_name: Castration Levels of Testosterone


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: UMLS:C2697511


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Her2-receptor negative breast cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEMBL.COMPOUND:CHEMBL2109514

object_name: metastatic melanoma


subject: UMLS:C1832014

subject_name: Anti-Melanin Monoclonal Antibody PTI-6D2


subject: DRUGBANK:DB16451

object_name: hepatitis C


subject: DRUGBANK:DB16451

object_name: chronic hepatitis C virus infection


subject: DRUGBANK:DB19037

subject_name: Cofirasersen

object_name: cystic fibrosis


subject: UMLS:C5925651

subject_name: Ionis-enacrx


subject: CHEBI:44915

subject_name: Propofol

object_name: Desflurane adverse reaction


subject: CHEBI:44915

object_name: Propofol adverse reaction


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Poisoning by, adverse effect of and underdosing of benzodiazepines


subject: PUBCHEM.COMPOUND:9824461

object_name: Benzodiazepine poisoning


subject: PUBCHEM.COMPOUND:9824461

object_name: Benzodiazepines causing adverse effects in therapeutic use


subject: PUBCHEM.COMPOUND:9824461

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:9824461

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:9824461

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:9824461

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:9824461

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:9824461

object_name: delirium


subject: PUBCHEM.COMPOUND:9824461

object_name: Delirium, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: cancer recurrence


subject: GTOPDB:7487

subject_name: alpha1-proteinase inhibitor

object_name: emphysema


subject: GTOPDB:7487

object_name: alpha 1-antitrypsin deficiency


subject: UMLS:C0795657

subject_name: Aralast


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C0002191


subject: CHEBI:4911

subject_name: Etoposide

object_name: trabecular adenocarcinoma


subject: CHEBI:4911

object_name: cutaneous neuroendocrine carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: UNII:3PEN569TJP

object_name: HIV infection


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Premature coronary artery atherosclerosis


subject: UNII:PP0SHH6V16

object_name: Inflammation


subject: UNII:PP0SHH6V16

object_name: lipoproteinemia


subject: UNII:PP0SHH6V16

object_name: acute coronary syndrome


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab


subject: UNII:LKC0U3A8NJ


subject: UNII:LKC0U3A8NJ


subject: CHEBI:29390

subject_name: silicon carbide

object_name: Iron deficiency


subject: CHEBI:29390

object_name: iron deficiency anemia


subject: UMLS:C5907898

object_name: pemphigus vulgaris


subject: CHEBI:8871

subject_name: Risperidone

object_name: developmental disability


subject: CHEBI:8871

object_name: Asperger syndrome


subject: CHEBI:8871

object_name: Rett syndrome


subject: UMLS:C5783950

subject_name: Anti-GD2 scFv/Anti-DOTA scFv Fusion Protein GD2-SADA

object_name: High Risk Neuroblastoma


subject: UMLS:C5783950

object_name: melanoma


subject: UMLS:C5783950

object_name: malignant soft tissue neoplasm


subject: UMLS:C5783950

object_name: sarcoma


subject: UMLS:C5783950

object_name: small cell carcinoma


subject: UMLS:C5783950

object_name: small cell lung carcinoma


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: cancer


subject: CHEBI:82677

object_name: neoplasm


subject: UNII:43OFW291R9

subject_name: TRIPTORELIN ACETATE

object_name: prostate carcinoma


subject: UNII:43OFW291R9

object_name: prostate cancer


subject: UMLS:C0771825

subject_name: triptorelin acetate


subject: UMLS:C0771825


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Color changes during tooth formation


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: infertility


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Uses contraception (finding)


subject: UNII:1L1V1K2M4V

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:2767

object_name: testicular germ cell tumor 1


subject: PUBCHEM.COMPOUND:2767

object_name: childhood testicular germ cell tumor


subject: PUBCHEM.COMPOUND:2767

object_name: extragonadal germ cell tumor


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864

object_name: testicular germ cell tumor


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: focal segmental glomerulosclerosis


subject: CHEBI:28061

subject_name: galactose


subject: CHEBI:42905

subject_name: L-Galactose


subject: KEGG.COMPOUND:C01582

subject_name: Galactose


subject: GTOPDB:4985

object_name: liver carcinoma


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3536908


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: allergic contact dermatitis


subject: UNII:ZG6U44T8SG

subject_name: INTISMERAN AUTOGENE

object_name: melanoma


subject: UNII:4Q2EZS1IWG

subject_name: Ethaselen

object_name: non-small cell lung carcinoma


subject: UMLS:C4744793

subject_name: Ginseng/Lingzhi Mushroom/Cordyceps sinensis/Rose Oral Liquid


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: Fever


subject: PUBCHEM.COMPOUND:135582802

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:135582802

object_name: Fever, CTCAE


subject: PUBCHEM.COMPOUND:135582802

object_name: leukopenia


subject: PUBCHEM.COMPOUND:135582802

object_name: neutropenia


subject: PUBCHEM.COMPOUND:135582802

object_name: gram-positive bacterial infections


subject: PUBCHEM.COMPOUND:135582802

object_name: Pseudomonas infection


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:8382

subject_name: Prednisone

object_name: Atopic rhinitis


subject: CHEBI:8382

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C5706461

subject_name: Rilvegostomig

object_name: Metastatic non-small cell lung cancer


subject: GTOPDB:13607

subject_name: danvatirsen


subject: UNII:31N550RD05

subject_name: Danvatirsen


subject: UMLS:C5417881

subject_name: Volrustomig


subject: GTOPDB:9596

subject_name: oleclumab


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UMLS:C4085967

subject_name: Oleclumab


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Ventral hernia


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Inguinal hernia


subject: UMLS:C4086546


subject: CHEBI:36162

subject_name: Hemoporfin

object_name: Port-Wine Stain


subject: CHEBI:90863

subject_name: Sonidegib

object_name: Locally Advanced Basal Cell Carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: acute mountain sickness


subject: CHEBI:41879

object_name: High altitude cerebral edema


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: multiple sclerosis


subject: UMLS:C0445115

subject_name: Normal saline

object_name: calcific tendinitis


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:33380

subject_name: thulium atom

object_name: hypoglycemia


subject: CHEBI:33380

object_name: Blood glucose below reference range (finding)


subject: CHEBI:33380

object_name: Hypoglycemia, CTCAE


subject: CHEBI:33380

object_name: type 1 diabetes mellitus 1


subject: CHEBI:33380

object_name: type 1 diabetes mellitus


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: CHEBI:30703


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: PR:000002105


subject: PR:000002105


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: inherited hemoglobinopathy


subject: CHEBI:44423

object_name: hemoglobinopathy


subject: CHEBI:20993

subject_name: GLUCOSAMINE

object_name: osteoarthritis susceptibility 6


subject: CHEBI:28393

subject_name: D-glucosamine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Aggressive behavior


subject: UMLS:C0301532

object_name: Aggression


subject: UMLS:C0301532

object_name: intellectual disability


subject: CHEBI:74705

subject_name: Met-Leu

object_name: coronary artery disorder


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C4733540

object_name: Advanced cancer


subject: CHEBI:149504

object_name: lung cancer


subject: CHEBI:149504

object_name: lung neoplasm


subject: CHEBI:149504

object_name: lung carcinoma


subject: CHEBI:149504

object_name: atrial fibrillation


subject: CHEBI:149504

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:149504

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: microscopic polyangiitis


subject: UNII:B72HH48FLU

object_name: granulomatosis with polyangiitis


subject: CHEBI:2965

object_name: hypertension


subject: CHEBI:2965

object_name: Hypertension, CTCAE


subject: CHEBI:2965

object_name: pure autonomic failure


subject: CHEBI:2965

object_name: multiple system atrophy


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C0379142


subject: UMLS:C3852696

object_name: Plasmodium falciparum malaria


subject: UNII:IHB5WLO51Q

subject_name: PIPERAQUINE TETRAPHOSPHATE


subject: UNII:5A17BAT3GK

subject_name: PIPERAQUINE PHOSPHATE


subject: UMLS:C3281828

subject_name: Piperaquine phosphate


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: Cardiac amyloidosis


subject: UNII:BMO5G62HGB

subject_name: FLORBETABEN


subject: CHEBI:79033

subject_name: florbetaben F18


subject: CHEBI:50885

subject_name: Fludrocortisone

object_name: primary orthostatic hypotension


subject: CHEBI:50885

object_name: Neurogenic Orthostatic Hypotension


subject: MESH:D002793

subject_name: Cholic Acids

object_name: peroxisome biogenesis disorder 1B


subject: MESH:D002793

object_name: peroxisomal disease


subject: MESH:D002793

object_name: Zellweger spectrum disorders


subject: MESH:D002793

object_name: adrenoleukodystrophy


subject: MESH:D002793

object_name: X-linked cerebral adrenoleukodystrophy


subject: MESH:D002793

object_name: cholestasis


subject: UMLS:C5554934

subject_name: FLT3 Inhibitor XY0206

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: PUBCHEM.COMPOUND:131674970

subject_name: CEFTRIAXONE SODIUM

object_name: Urinary tract infections in children


subject: PUBCHEM.COMPOUND:131674970

object_name: respiratory tract infectious disorder


subject: CHEBI:3514

subject_name: Ceftriaxone disodium salt hemiheptahydrate


subject: CHEBI:3514


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: CHEBI:15407

subject_name: Ephedrine

object_name: hypotension


subject: CHEBI:15407

object_name: Hypotension, CTCAE


subject: UNII:V5Y646AW8S

object_name: Freezing of gait


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: UMLS:C4683805

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C4683805

object_name: Recurrent Glioblastoma


subject: UMLS:C4683805

object_name: glioblastoma


subject: UMLS:C4683805

object_name: Childhood Glioblastoma


subject: UMLS:C4683805

object_name: adult glioblastoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:49900

subject_name: Arsenous acid


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: DRUGBANK:DB18330

subject_name: Yinfenidone

object_name: interstitial lung disease 1


subject: DRUGBANK:DB18330

object_name: interstitial lung disease 2


subject: UMLS:C5853983


subject: UMLS:C5853983


subject: UMLS:C0873019

subject_name: Berberine hydrochloride

object_name: Blood Pressure Finding


subject: UMLS:C0873019

object_name: Systemic arterial pressure


subject: UMLS:C0873019

object_name: hypertension


subject: UMLS:C0873019

object_name: Hypertension, CTCAE


subject: UMLS:C0873019

object_name: coronary microvascular disorder


subject: CHEBI:231352

subject_name: Resminostat

object_name: Hodgkin Disease


subject: UMLS:C2827533


subject: CHEBI:9349

subject_name: Dimethyl sulfone

object_name: osteoarthritis


subject: CHEBI:17437

subject_name: Dimethylsulfide


subject: CHEMBL.COMPOUND:CHEMBL4298093

subject_name: SEMORINEMAB

object_name: Alzheimer disease


subject: UMLS:C5139915

subject_name: Semorinemab


subject: UMLS:C5396052

subject_name: Inactivated whole Hepatitis A virus antigen only vaccine product

object_name: hepatitis A


subject: UMLS:C5396052

object_name: hepatitis B


subject: UMLS:C5396052

object_name: meningococcal meningitis


subject: UMLS:C5396052

object_name: meningococcal infection


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: DRUGBANK:DB11627


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: primary central nervous system lymphoma


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW

object_name: head and neck squamous cell carcinoma


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: chronic kidney disease


subject: CHEBI:35475

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UMLS:C0358845


subject: UNII:681K1JDI8M

subject_name: Valoctocogene roxaparvovec

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: UNII:681K1JDI8M

object_name: Haemophilia A with anti factor VIII


subject: CHEBI:31355

subject_name: Carboplatin

object_name: High grade glioma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: central nervous system neoplasm


subject: CHEBI:4026

object_name: central nervous system cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:195558

object_name: malignant glioma


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:YTL7A418KQ

subject_name: Nanatinostat

object_name: Childhood Solid Neoplasm


subject: UNII:YTL7A418KQ

object_name: Adult Solid Neoplasm


subject: UNII:YTL7A418KQ

object_name: Solid Neoplasm


subject: UMLS:C2703120


subject: UMLS:C2703120


subject: UMLS:C2703120


subject: CHEBI:5441

subject_name: Glyburide

object_name: Gestational diabetes mellitus class A2


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:3423

subject_name: Carmustine

object_name: CD19 Positive


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: B-cell lymphoma refractory


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C4731334

subject_name: Dalfampridine ER

object_name: multiple sclerosis


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Traumatic Wound


subject: CHEBI:3160

object_name: Injury


subject: CHEBI:3160

object_name: Wounds and Injuries


subject: CHEBI:3160

object_name: Chronic ulcer of lower extremity


subject: CHEBI:49575

subject_name: Diazepam

object_name: levator syndrome


subject: CHEBI:23965

subject_name: estradiol

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:23965

object_name: Progesterone Receptor Positive


subject: CHEBI:23965

object_name: Progesterone Receptor Negative


subject: CHEBI:23965

object_name: HER2/Neu Negative


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Cardiac Output


subject: CHEBI:8093

object_name: cardiac catheterization cardiac output in liters per minute


subject: UNII:865UEK4EJC

subject_name: Elobixibat

object_name: Chronic idiopathic constipation


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: thrombophilia due to activated protein C resistance


subject: UNII:52CMI0WC3Y

object_name: Microsatellite Instability


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Medial Malleolus Fractures


subject: CHEBI:7852

object_name: Lateral Malleolus Fractures


subject: UNII:4JEH3BL51N

object_name: Alzheimer disease


subject: MESH:C000633777


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Vomiting, CTCAE


subject: CHEBI:42797

object_name: Vomiting


subject: CHEBI:42797

object_name: Cisplatin adverse reaction


subject: CHEBI:8707

subject_name: Quetiapine

object_name: methamphetamine dependence


subject: DRUGBANK:DB16196

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297705

object_name: Advanced cancer


subject: UMLS:C4287779

subject_name: anti-OX40 antibody BMS 986178


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5417778

subject_name: Allogeneic Autophagosome-enriched Vaccine DPV-001


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C5240013

subject_name: Vaccine product containing only Clostridium tetani antigen (medicinal product)


subject: MESH:D013608

subject_name: Tablets, Enteric-Coated

object_name: intrahepatic cholestasis


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Alzheimer disease type 1


subject: UNII:37KZM6S21G


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: liver carcinoma


subject: UMLS:C4085970


subject: UMLS:C0754326

subject_name: Optison

object_name: carotid artery disorder


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: asthma


subject: CHEBI:231683

subject_name: Anakinra

object_name: neurotoxicity


subject: CHEBI:231683

object_name: Cytokine Release Syndrome, CTCAE


subject: CHEBI:231683

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:231683

object_name: non-Hodgkin lymphoma


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel


subject: UNII:U2I8T43Y7R

object_name: cytokine release syndrome


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: UNII:U2I8T43Y7R


subject: DRUGBANK:DB09447

subject_name: Technetium Tc-99m albumin colloid

object_name: carcinoma


subject: DRUGBANK:DB09447


subject: DRUGBANK:DB09447

object_name: liver neoplasm


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Invasive fungal infection


subject: UMLS:C1442922

subject_name: Lamb antigen


subject: DRUGBANK:DB10537

subject_name: Lamb


subject: PR:000023072

subject_name: maltoporin


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Plasma cell myeloma refractory


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: heart failure


subject: CHEBI:6062

object_name: Heart Failure, CTCAE


subject: UNII:D86MF5H9WJ

subject_name: Cemsidomide

object_name: plasma cell myeloma


subject: CHEBI:61080

subject_name: Romidepsin

object_name: ovarian cancer


subject: CHEBI:61080

object_name: ovarian neoplasm


subject: CHEBI:61080

object_name: ovarian carcinoma


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic


subject: UMLS:C4082795


subject: UMLS:C4082795


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: PUBCHEM.COMPOUND:3962

object_name: chronic obstructive pulmonary disease


subject: CHEBI:40303

subject_name: Lovastatin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Myelofibrosis due to another disorder


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C4287789

object_name: psoriasis


subject: UMLS:C5827056

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5827056

object_name: amyotrophic lateral sclerosis


subject: CHEBI:4875

subject_name: Etanercept

object_name: osteoarthritis susceptibility 6


subject: CHEBI:4875

object_name: osteoarthritis, knee


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: TRAUMA/INJURY PROBLEM


subject: UMLS:C5446586

subject_name: P2RX3 Antagonist BAY 1817080

object_name: Drug Interactions


subject: UMLS:C5782769

subject_name: BUPivacaine 0.5% injectable solution

object_name: Hemodynamic stability


subject: CHEBI:68554

subject_name: Deferiprone

object_name: neurodegenerative disease


subject: CHEBI:76842

object_name: infective endocarditis


subject: CHEBI:76842

object_name: bacterial endocarditis


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: UMLS:C0719238

subject_name: CETAPHIL CREAM

object_name: atopic eczema


subject: UMLS:C0719238

object_name: dermatitis


subject: UMLS:C0719238

object_name: Eczema, CTCAE


subject: UNII:3W1JG795YI

subject_name: SUNFLOWER OIL


subject: UNII:3W1JG795YI


subject: UNII:3W1JG795YI


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: BREAST CANCER NOS METASTATIC RECURRENT


subject: CHEBI:4026

object_name: neuropathy


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Malignant Solid Neoplasm


subject: CHEBI:231005


subject: CHEBI:231005


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:8774

subject_name: Ramipril

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: cocaine abuse


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:135533

subject_name: Talinolol


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: mycosis fungoides


subject: UMLS:C4053601


subject: CHEBI:9112

subject_name: sennoside A

object_name: Pruritus, CTCAE


subject: CHEBI:9112

object_name: Pruritus


subject: CHEBI:9112

object_name: end stage renal failure


subject: CHEBI:9112

object_name: Chronic uremia


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: Childhood Breast Carcinoma


subject: UNII:4B93MGE4AL

object_name: breast carcinoma


subject: UNII:4B93MGE4AL

object_name: breast cancer


subject: UNII:4B93MGE4AL

object_name: Stomach cancer


subject: UNII:4B93MGE4AL

object_name: gastric cancer


subject: UNII:4B93MGE4AL

object_name: cholangiocarcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2269

object_name: bacterial pneumonia


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin


subject: UNII:HLF8J24L87

object_name: type 2 diabetes mellitus


subject: UNII:HLF8J24L87

object_name: inherited lipid metabolism disorder


subject: UNII:HLF8J24L87

object_name: Dyslipidemia


subject: UMLS:C0595334

subject_name: Zanidip

object_name: hypertension


subject: UMLS:C0595334

object_name: Hypertension, CTCAE


subject: CHEBI:8888

subject_name: Ropinirole

object_name: cocaine dependence


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:31684

subject_name: Ibudilast

object_name: migraine


subject: CHEBI:82814

subject_name: Dilacor XR

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:82814

object_name: pulmonary hypertension


subject: CHEBI:82814

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:82814

object_name: pulmonary arterial hypertension


subject: CHEBI:82814

object_name: primary pulmonary hypertension


subject: CHEBI:82814

object_name: heritable pulmonary arterial hypertension


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:101278


subject: UMLS:C3274911

subject_name: Gliolan

object_name: Childhood Brain Neoplasm


subject: PUBCHEM.COMPOUND:21865528

object_name: dilated cardiomyopathy


subject: CHEBI:188730

subject_name: Ifetroban


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: obesity


subject: PUBCHEM.COMPOUND:3080587

object_name: infertility


subject: PUBCHEM.COMPOUND:3080587

object_name: Overweight


subject: UMLS:C5392518

object_name: neuroendocrine neoplasm


subject: UMLS:C5392518

object_name: APUdoma


subject: GTOPDB:13607

subject_name: danvatirsen

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:13607

object_name: acute myeloid leukemia


subject: GTOPDB:13607

object_name: Myelodysplasia


subject: GTOPDB:13607

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UNII:31N550RD05

subject_name: Danvatirsen


subject: UNII:31N550RD05


subject: UNII:31N550RD05


subject: UNII:31N550RD05


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: cervical cancer


subject: UMLS:C3852764

object_name: cervical carcinoma


subject: CHEBI:66964

subject_name: Dronabinol

object_name: complex regional pain syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297740

subject_name: DARLEUKIN

object_name: metastatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297740

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL4297740

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL4297740

object_name: Metastatic Lesion


subject: CHEMBL.COMPOUND:CHEMBL4297740

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C2983744

subject_name: Darleukin


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: UMLS:C2983744


subject: CHEBI:6129

subject_name: Ketorolac

object_name: urolithiasis


subject: CHEBI:6754

subject_name: Meperidine

object_name: pain agnosia


subject: CHEBI:6754

object_name: Pain insensitivity


subject: CHEBI:6754


subject: UMLS:C0358463

subject_name: Xylocaine gel


subject: UMLS:C0358463


subject: UMLS:C0358463


subject: UMLS:C4287754

subject_name: Ragifilimab

object_name: glioblastoma


subject: UMLS:C4287754

object_name: Childhood Glioblastoma


subject: UMLS:C4287754

object_name: adult glioblastoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:49132

subject_name: FLUDEOXYGLUCOSE

object_name: pulmonary hypertension


subject: CHEBI:49132

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:50924

subject_name: Sorafenib

object_name: FLT3 Internal Tandem Duplication


subject: UNII:T79C086548

subject_name: CONTEZOLID ACEFOSAMIL

object_name: Diabetic foot infection


subject: UMLS:C5418335

subject_name: Contezolid Acefosamil


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:B669M62ELP

subject_name: MRX-I


subject: CHEBI:33313

subject_name: polonium atom


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Postoperative Complications


subject: CHEBI:5931

subject_name: insulin human


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: kidney disorder


subject: UMLS:C1577331

subject_name: Vitrase

object_name: vitreous detachment


subject: CHEBI:521033

subject_name: Dutasteride

object_name: alopecia


subject: CHEBI:521033

object_name: Alopecia, CTCAE


subject: UNII:B0SV3N7J3H

subject_name: Bicifadine

object_name: Chronic low back pain


subject: CHEBI:8988

object_name: Effects of chemotherapy


subject: CHEBI:80630

subject_name: Irinotecan


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: GTOPDB:7988


subject: GTOPDB:7988


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:31355

subject_name: Carboplatin

object_name: grade 3B follicular lymphoma


subject: CHEBI:31355

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:135565596


subject: PUBCHEM.COMPOUND:135565596

object_name: Diffuse large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:135565596


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0008586

subject_name: Chromogranins

object_name: staphylococcus aureus infection


subject: UMLS:C0008586

object_name: staphylococcal infection


subject: UMLS:C0008586

object_name: Staphylococcal Skin Infections


subject: UMLS:C0008586

object_name: Community-Acquired Infections


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: pneumonitis


subject: CHEBI:8228

object_name: pneumonia


subject: CHEBI:10112

subject_name: Zileuton


subject: CHEBI:10112


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Uses contraception (finding)


subject: PUBCHEM.COMPOUND:21628493

object_name: Pregnant


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: lung adenocarcinoma


subject: CHEBI:233362

object_name: malignant glioma


subject: CHEBI:233362

object_name: lung cancer


subject: CHEBI:233362

object_name: lung neoplasm


subject: CHEBI:233362

object_name: lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Conjunctival scar


subject: PUBCHEM.COMPOUND:23582788

subject_name: Tegoprazan

object_name: Peptic Ulcer Hemorrhage


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3896914


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: prostate carcinoma


subject: CHEBI:9984

object_name: prostate cancer


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: Disorder of retina caused by radiation


subject: UNII:QC4F7FKK7I

object_name: blindness


subject: UNII:QC4F7FKK7I

object_name: Impaired Vision


subject: CHEBI:31623

subject_name: Fluocinolone acetonide


subject: CHEBI:31623


subject: CHEBI:31623


subject: UMLS:C0658617

object_name: urothelial carcinoma


subject: UMLS:C0658617

object_name: transitional cell carcinoma


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:16VY3TM7ZO

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:16VY3TM7ZO

object_name: Ovarian cancer stage IV


subject: UNII:16VY3TM7ZO

object_name: Ovarian cancer stage III


subject: UNII:16VY3TM7ZO

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Pancoast tumor


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV

object_name: stage IIB non-small cell lung cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: MESH:C079198


subject: MESH:C079198

object_name: Non-small cell lung cancer stage III


subject: CHEBI:16302

object_name: Sepsis


subject: CHEBI:16302

object_name: Sepsis, CTCAE


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: renal carcinoma


subject: UMLS:C4510275

object_name: kidney neoplasm


subject: UMLS:C4510275

object_name: kidney cancer


subject: UMLS:C2077028

subject_name: inhaled beclomethasone dipropionate monohydrate

object_name: bronchopulmonary dysplasia


subject: UMLS:C2077028

object_name: Bronchopulmonary Dysplasia, AE


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: peripheral vascular disease


subject: GTOPDB:4942

object_name: peripheral arterial disease


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Well adult


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C0994331

subject_name: TAMOXIFEN CITRATE, ORAL, 10MG ADMINISTERED

object_name: Childhood Breast Carcinoma


subject: UMLS:C0994331

object_name: breast carcinoma


subject: UMLS:C0994331

object_name: breast cancer


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:38290

object_name: chronic myelomonocytic leukemia


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C0136589

subject_name: phenoptin

object_name: hyperphenylalaninemia due to tetrahydrobiopterin deficiency


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:63791

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:63791

object_name: Adult Acute Basophilic Leukemia


subject: CHEBI:63791

object_name: Adult Acute Eosinophilic Leukemia


subject: CHEBI:77733

subject_name: Verapamil

object_name: Regional anesthesia morbidity


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: carnitine palmitoyltransferase II deficiency


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: colorectal carcinoma


subject: UMLS:C2699335

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Surgical procedure finding


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:52717

subject_name: Bortezomib

object_name: precancerous condition


subject: CHEBI:75929

object_name: specific phobia


subject: CHEBI:40009

subject_name: Cycloserine


subject: PUBCHEM.COMPOUND:90408860

object_name: bipolar disorder


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Myelodysplasia


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Primary malignant neoplasm


subject: CHEBI:59902

object_name: cancer


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: CHEBI:4856

subject_name: Esmolol

object_name: Cognitive impairment


subject: UMLS:C5691164

subject_name: BromAc

object_name: Acetylcysteine adverse reaction


subject: UMLS:C5691164

object_name: Acute respiratory distress syndrome due to COVID-19


subject: UMLS:C5691164

object_name: Bromelains adverse reaction


subject: UMLS:C5691164

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:9123

subject_name: Sertraline

object_name: Anxiety disorder of adolescence


subject: CHEBI:90942

subject_name: Ixazomib

object_name: amyloidosis


subject: CHEBI:90881

subject_name: Camptosar

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:90881

object_name: rhabdomyosarcoma


subject: CHEBI:90881

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:90881

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:90881

object_name: alveolar rhabdomyosarcoma


subject: CHEBI:90881

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:90881

object_name: childhood botryoid rhabdomyosarcoma


subject: CHEBI:90881

object_name: Stage III Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:90881

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:90881

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:90881

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:53438230

object_name: melanoma


subject: PUBCHEM.COMPOUND:53438230

object_name: colorectal carcinoma


subject: UMLS:C1832009


subject: UMLS:C1832009


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: heart failure


subject: PUBCHEM.COMPOUND:74328238

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:74328238

object_name: chronic kidney disease


subject: CHEBI:94366

subject_name: itraconazole

object_name: neoplasm of esophagus


subject: CHEBI:94366

object_name: esophageal disorder


subject: CHEBI:7772

subject_name: omeprazole

object_name: gastric mucosa-associated lymphoid tissue lymphoma


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:94688

subject_name: Acipimox

object_name: Android obesity


subject: CHEBI:94688

object_name: Abdominal obesity


subject: CHEBI:36796

subject_name: duloxetine

object_name: herpes zoster


subject: CHEBI:36796

object_name: postherpetic neuralgia


subject: UMLS:C3642455

subject_name: BTK inhibitor CC-292

object_name: B-CELL MALIGNANCY, LOW-GRADE


subject: UMLS:C3642455

object_name: leukemia, chronic lymphocytic, susceptibility to, 2


subject: UMLS:C3642455

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: PUBCHEM.COMPOUND:53318955

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:10455984


subject: MESH:C542785


subject: CHEBI:60802

subject_name: ropivacaine

object_name: post-traumatic stress disorder


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:34385

object_name: progressive relapsing multiple sclerosis


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:164886680

subject_name: Certepetide

object_name: Matthew-Wood syndrome


subject: PUBCHEM.COMPOUND:164886680

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:164886680

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:164886680

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:164886680

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:164886680

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: DRUGBANK:DB18721


subject: CHEBI:4445

subject_name: Desflurane

object_name: obesity


subject: CHEBI:8802

subject_name: Remifentanil


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: skin disorder


subject: PUBCHEM.COMPOUND:138713709

object_name: Genodermatosis


subject: PUBCHEM.COMPOUND:138713709

object_name: epidermolysis bullosa simplex


subject: PUBCHEM.COMPOUND:138713709

object_name: ichthyosis


subject: PUBCHEM.COMPOUND:138713709

object_name: inherited ichthyosis


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage IIA Breast Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage IIB Breast Carcinoma


subject: UNII:K16AIQ8CTM

object_name: malignant neoplasm of breast stage IIb


subject: UNII:K16AIQ8CTM

object_name: inflammatory breast carcinoma


subject: UNII:K16AIQ8CTM

object_name: breast adenocarcinoma


subject: CHEBI:82339

subject_name: Merphalan

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:82339

object_name: Embolism, Tumor


subject: CHEBI:82339

object_name: Neoplasm Metastasis


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Female infertility due to diminished ovarian reserve


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C3896749

object_name: Childhood Glioblastoma


subject: UMLS:C3896749

object_name: adult glioblastoma


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Injury


subject: CHEBI:135207

object_name: Trauma


subject: CHEBI:135207

object_name: Injury of vertebral artery


subject: CHEBI:135207

object_name: Carotid Artery Injuries


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:15365


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: non-small cell lung carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: aspiration pneumonia


subject: CHEBI:63611

object_name: aspiration pneumonitis


subject: CHEBI:63611

object_name: lung abscess


subject: CHEBI:4445

object_name: carotid stenosis


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: marginal zone lymphoma


subject: UNII:LDJ89SS0YG

object_name: MALT lymphoma


subject: UNII:LDJ89SS0YG

object_name: follicular lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: metastatic colorectal cancer


subject: UMLS:C4053601


subject: CHEBI:9570

subject_name: Thiotepa

object_name: Adult Burkitt Lymphoma


subject: CHEBI:9570

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:9570

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:567361

subject_name: Cladribine

object_name: Burkitt lymphoma


subject: CHEBI:567361

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:567361


subject: CHEBI:567361


subject: CHEBI:567361


subject: UMLS:C3884609


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human

object_name: melanoma


subject: PR:000024938

subject_name: interferon alpha


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Adverse reaction to penicillins


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C5565764

subject_name: Novavax vaccine

object_name: Upper Respiratory Infections


subject: UMLS:C5565764

object_name: upper respiratory tract disorder


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: prostate neoplasm


subject: UMLS:C5941101

subject_name: Revaree Plus

object_name: Childhood Breast Carcinoma


subject: UMLS:C5941101

object_name: breast carcinoma


subject: UMLS:C5941101

object_name: breast cancer


subject: UMLS:C5941101

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: breast carcinoma in situ


subject: UMLS:C5941101

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: malignant neoplasm of breast stage I


subject: UMLS:C5941101

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: Carcinoma breast stage I


subject: UMLS:C5941101

object_name: Breast cancer stage II


subject: UMLS:C5941101

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C5941101

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C5941101

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: Breast cancer stage III


subject: UMLS:C5941101

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C5941101

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5941101

object_name: hormone receptor-positive breast cancer


subject: UMLS:C5941101

object_name: Breast carcinoma NOS stage III


subject: UMLS:C5941101

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C5941101

object_name: Hormone receptor positive malignant neoplasm of breast


subject: UMLS:C4745007

subject_name: Goserelin Acetate Extended-release Microspheres LY01005

object_name: prostate carcinoma


subject: UMLS:C4745007

object_name: prostate cancer


subject: MESH:C000722753

subject_name: ACM-001 COVID-19 vaccine


subject: CHEBI:5062

subject_name: Finasteride

object_name: polycythemia


subject: MESH:C000631489

object_name: plasma cell myeloma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UNII:4F4X42SYQ6

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UNII:4F4X42SYQ6

object_name: Follicular lymphoma stage II


subject: UNII:4F4X42SYQ6

object_name: Follicle centre lymphoma, follicular grade I, II, III stage IV


subject: UNII:4F4X42SYQ6

object_name: Follicular lymphoma stage III


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z

object_name: grade 3A follicular lymphoma


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: CHEBI:63612

subject_name: Nelarabine

object_name: cancer


subject: CHEBI:63612

object_name: neoplasm


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Surgical procedure finding


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: UNII:1326R5J1IA

subject_name: FET F-18

object_name: glioblastoma


subject: UNII:1326R5J1IA

object_name: Brain Stem Glioblastoma


subject: UNII:1326R5J1IA

object_name: glioma susceptibility 1


subject: UMLS:C1831729


subject: UMLS:C1831729


subject: UMLS:C1831729


subject: CHEBI:6432

subject_name: Levamisole

object_name: anemia


subject: CHEBI:6432

object_name: Anemia, CTCAE


subject: CHEBI:6432

object_name: autoimmune hemolytic anemia


subject: CHEBI:6432

object_name: Autoimmunity


subject: CHEBI:6432

object_name: Hemolysis


subject: CHEBI:6432

object_name: Hemolysis - observation


subject: CHEBI:6432

object_name: Hemolysis, CTCAE


subject: CHEBI:6432

object_name: immune system disorder


subject: CHEBI:6432

object_name: hematologic disorder


subject: CHEBI:6432

object_name: Pathologic Processes


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: infective endocarditis


subject: CHEBI:2676

object_name: bacterial endocarditis


subject: CHEBI:2676

object_name: Endocarditis Infective, CTCAE


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:4511

subject_name: Dicloxacillin


subject: CHEBI:4511


subject: CHEBI:4511


subject: UMLS:C4756473

subject_name: Fusidic acid only product in oral dose form


subject: UMLS:C4756473


subject: UMLS:C4756473


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:63607


subject: CHEBI:63607


subject: UMLS:C4757500

subject_name: Rifampin only product in oral dose form


subject: UMLS:C4757500


subject: UMLS:C4757500


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:82717

subject_name: Tedizolid


subject: CHEBI:82717


subject: CHEBI:82717


subject: PUBCHEM.COMPOUND:2609

subject_name: cefaclor


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: CHEBI:3745


subject: UNII:IS3ESI44W5

object_name: plasma cell myeloma


subject: UNII:IS3ESI44W5

object_name: kidney failure


subject: UMLS:C2703201


subject: UMLS:C2703201


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: pancreatic neoplasm


subject: UNII:M170940PMI

object_name: exocrine pancreatic carcinoma


subject: UNII:M170940PMI

object_name: malignant pancreatic neoplasm


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Ewing sarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:50693

subject_name: Milrinone

object_name: persistent fetal circulation syndrome


subject: CHEBI:50693

object_name: alveolar capillary dysplasia with misalignment of pulmonary veins


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: Congenital IGHD


subject: UMLS:C0037668

object_name: Reduced circulating growth hormone concentration


subject: UNII:4UR7N9Z9MM

subject_name: Somatorelin


subject: UNII:4UR7N9Z9MM


subject: GTOPDB:3602

subject_name: GHRH


subject: GTOPDB:3602


subject: UNII:6L5D03D975

subject_name: Ilorasertib

object_name: Embolism, Tumor


subject: UNII:6L5D03D975

object_name: Solid Neoplasm


subject: UNII:6L5D03D975

object_name: Unresectable Malignant Neoplasm


subject: CHEBI:23359

subject_name: colchicine

object_name: osteoarthritis, knee


subject: CHEBI:23359

object_name: osteoarthritis, hip


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: migraine


subject: UMLS:C1527137

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Postoperative Nausea


subject: CHEBI:3077

object_name: Vomiting, Postoperative


subject: CHEBI:4717

subject_name: Droperidol


subject: CHEBI:4717


subject: CHEBI:85990

subject_name: Panobinostat

object_name: graft versus host disease


subject: CHEBI:85990

object_name: acquired polycythemia vera


subject: CHEBI:85990

object_name: thalassemia


subject: CHEBI:85990

object_name: myelofibrosis


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: psoriasis


subject: UMLS:C4055180

subject_name: Copper Cu 64-DOTA B-Fab

object_name: breast carcinoma


subject: UMLS:C4055180

object_name: ovarian cancer


subject: UMLS:C4055180

object_name: ovarian carcinoma


subject: UMLS:C4055180

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:167993670

object_name: Advanced Urothelial Carcinoma


subject: UMLS:C5854628

subject_name: PPAR Gamma Inhibitor FX-909


subject: UNII:4K58KV52ZM


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: pneumonia


subject: PUBCHEM.COMPOUND:9852982

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: UMLS:C5206703

subject_name: INCAGN 02390

object_name: urothelial carcinoma


subject: UMLS:C5206703

object_name: transitional cell carcinoma


subject: GTOPDB:8221

subject_name: epacadostat


subject: GTOPDB:8221


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: PUBCHEM.COMPOUND:3962

object_name: Rett syndrome


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:29888

subject_name: Pyrophosphate

object_name: pseudoxanthoma elasticum (inherited or acquired)


subject: CHEBI:29888

object_name: elastoma


subject: CHEBI:29888

object_name: autosomal recessive inherited pseudoxanthoma elasticum


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: glioblastoma


subject: UNII:28X28X9OKV

object_name: Childhood Glioblastoma


subject: UNII:28X28X9OKV

object_name: adult glioblastoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Breast cancer stage II


subject: CHEBI:45716

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:45716

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Childhood Breast Carcinoma


subject: CHEBI:45716

object_name: breast carcinoma


subject: CHEBI:45716

object_name: breast cancer


subject: CHEBI:45716

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:45716

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Breast cancer stage III


subject: CHEBI:45716

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:45716

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: malignant neoplasm of breast stage I


subject: CHEBI:45716

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Carcinoma breast stage I


subject: CHEBI:135041

subject_name: phenbenzamine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:135041


subject: CHEBI:135041

object_name: neurodevelopmental disorder


subject: CHEBI:135041

object_name: oppositional defiant disorder


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib


subject: CHEBI:10033

subject_name: Warfarin


subject: UMLS:C0520158

subject_name: Injection, irinotecan, 20 mg administered

object_name: esophageal squamous cell carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:74947

subject_name: Thalidomide

object_name: inflammatory bowel disease


subject: CHEBI:167309

subject_name: Methadone

object_name: Congenital postural scoliosis


subject: CHEBI:167309

object_name: scoliosis


subject: CHEBI:167309

object_name: Scoliosis, CTCAE


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:596

object_name: sarcoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: UMLS:C3898779

object_name: malignant glioma


subject: UMLS:C3898779

object_name: Recurrent Brain Neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Urinary Retention


subject: CHEBI:74705

object_name: Urinary Retention, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:8884

subject_name: Rocuronium

object_name: end stage renal failure


subject: CHEBI:8884

object_name: Chronic uremia


subject: CHEBI:27732

subject_name: Caffeine

object_name: Exposure to cold


subject: UMLS:C4085979

object_name: neoplasm


subject: PUBCHEM.COMPOUND:156963498

subject_name: Mecapegfilgrastim

object_name: small cell lung carcinoma


subject: UNII:I4QL0KKG3K

subject_name: pegylated granulocyte colony-stimulating factor


subject: CHEMBL.COMPOUND:CHEMBL5095279

subject_name: MECAPEGFILGRASTIM


subject: UMLS:C3179328


subject: UMLS:C2703169

object_name: malignant pleural mesothelioma


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: Adult Meningioma


subject: CHEBI:232328

object_name: benign meningioma


subject: CHEBI:232328

object_name: familial meningioma


subject: CHEBI:232328

object_name: pediatric meningioma


subject: CHEBI:232328

object_name: meningioma


subject: CHEBI:232328

object_name: Refractory Meningioma


subject: CHEBI:232328

object_name: Recurrent Meningioma


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: UMLS:C3827072


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: infertility


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Postoperative Complications


subject: CHEBI:6129

object_name: Ketorolac adverse reaction


subject: CHEBI:6129

object_name: Tibial Meniscus Tears


subject: MESH:C514822

subject_name: oxycodone-acetaminophen


subject: MESH:C514822

object_name: opioid use


subject: MESH:C514822


subject: MESH:C514822


subject: UMLS:C0717368

subject_name: acetaminophen / oxycodone


subject: UMLS:C0717368


subject: UMLS:C0717368


subject: UMLS:C0717368


subject: CHEBI:3219

subject_name: Bupropion

object_name: sickle cell disease


subject: CHEBI:42446

subject_name: Esflurbiprofen


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:8805

subject_name: Repaglinide


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:499361

subject_name: Aprepitant

object_name: chronic obstructive pulmonary disease


subject: CHEBI:36791

subject_name: Escitalopram

object_name: other psychiatric disorders


subject: CHEBI:36791

object_name: traumatic encephalopathy


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:118310260

object_name: acute myeloid leukemia


subject: UMLS:C4330930


subject: CHEBI:187893

subject_name: Baclofen

object_name: nicotine dependence


subject: GTOPDB:11827

subject_name: telitacicept

object_name: EXCESS LMW-DNA


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Waldenstrom macroglobulinemia


subject: UNII:D6OMY2L0WA

object_name: B-Cell Lymphoproliferative Disorder


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: corneal intraepithelial neoplasm


subject: UNII:43K1W2T1M6

object_name: conjunctival intraepithelial neoplasm


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625


subject: CHEBI:194095

subject_name: mitomycin C(1-)


subject: CHEBI:194095


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: Blood Clot


subject: UMLS:C3714648

object_name: thrombosis


subject: UMLS:C3714648

object_name: Thrombosis of blood vessel


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C2936884


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:47458

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:47458

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:47458

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:47458

object_name: Stage III Uterine Sarcoma AJCC v7


subject: CHEBI:47458

object_name: Stage IV Uterine Sarcoma AJCC v7


subject: CHEBI:47458

object_name: endometrioid stromal sarcoma


subject: CHEBI:47458

object_name: adult liposarcoma


subject: CHEBI:47458

object_name: adult fibrosarcoma


subject: CHEBI:47458

object_name: Adult Leiomyosarcoma


subject: CHEBI:47458

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:47458

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:47458

object_name: uterine carcinosarcoma


subject: CHEBI:47458

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:47458

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:47458

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C3467950

object_name: membranous glomerulonephritis


subject: UMLS:C3467950


subject: CHEBI:231602

subject_name: Refametinib

object_name: biliary tract cancer


subject: CHEBI:231602

object_name: liver carcinoma


subject: CHEBI:93775

subject_name: Amethopterin

object_name: inflammatory spondylopathy


subject: CHEBI:93775

object_name: spondyloarthropathy


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: microscopic polyangiitis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Outcome of Therapy


subject: CHEBI:76016

object_name: Best Overall Response


subject: CHEBI:174615

object_name: autosomal recessive osteopetrosis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:8499

subject_name: Propranolol

object_name: proliferative diabetic retinopathy


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Grade 1 Hypertension, CTCAE


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: UMLS:C5786907

object_name: small cell lung carcinoma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: age-related macular degeneration


subject: UNII:FYS6T7F842

object_name: choroidal neovascularization


subject: UNII:FYS6T7F842

object_name: choroidal neovascularization (physical finding)


subject: CHEBI:600103

subject_name: daptomycin

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: UMLS:C1699394

subject_name: Hylenex

object_name: neoplasm


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: UNII:5X5HB3VZ3Z

subject_name: Apricoxib

object_name: pancreatic neoplasm


subject: UNII:5X5HB3VZ3Z

object_name: exocrine pancreatic carcinoma


subject: UNII:5X5HB3VZ3Z

object_name: malignant pancreatic neoplasm


subject: UNII:5X5HB3VZ3Z

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Barrett esophagus


subject: CHEBI:94366

subject_name: itraconazole

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Soft Tissue Infection


subject: CHEBI:51254

object_name: skin disorder caused by infection


subject: CHEBI:51254

object_name: skin infection


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Chronic liver disease


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Bone fracture


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:102216

subject_name: Methohexital

object_name: Depressed mood


subject: CHEBI:102216

object_name: Cancer patients and suicide and depression


subject: CHEBI:102216

object_name: Depressed - symptom


subject: CHEBI:102216

object_name: Depression, CTCAE


subject: UNII:6H81G454I7

object_name: schizophrenia


subject: PR:000004765

subject_name: biliverdin reductase A

object_name: emphysema


subject: PR:000004765

object_name: chronic obstructive pulmonary disease


subject: UNII:P6YC3EG204

subject_name: Erythrotin

object_name: inborn disorder of cobalamin metabolism and transport


subject: CHEBI:15982

subject_name: cob(I)alamin


subject: UMLS:C3714801

subject_name: Cyanocobalamin Drug Class


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:6095520

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: PUBCHEM.COMPOUND:89465


subject: CHEBI:3309

subject_name: Calcium gluconate


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:3309


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599

object_name: Breast cancer recurrent


subject: CHEBI:233453

object_name: Urinary Urgency


subject: CHEBI:233453

object_name: outcomes general quality of life


subject: CHEBI:233453

object_name: Perceived quality of life


subject: CHEBI:233453

object_name: Good quality of life


subject: CHEBI:233453

object_name: urgency urinary incontinence


subject: CHEBI:233453

object_name: Chronic pain


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:94366

object_name: Nocturia


subject: UNII:VX2GBO4I0V

subject_name: Fedovapagon


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Diabetes


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347

object_name: diabetes mellitus


subject: CHEBI:8774

subject_name: Ramipril

object_name: type 2 diabetes mellitus


subject: CHEBI:8774


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: chronic graft versus host disease


subject: UMLS:C0378942


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4

object_name: prostate carcinoma


subject: UMLS:C3495434

object_name: prostate cancer


subject: CHEBI:2965

object_name: coronary artery disorder


subject: UMLS:C0379142


subject: UNII:44OLL8XEJ4


subject: UMLS:C0253336


subject: CHEBI:80240


subject: UNII:2K62B8Z6XF


subject: MESH:D019444

subject_name: Vaccines, DNA


subject: MESH:D019444


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Chronic Daily Headache


subject: PUBCHEM.COMPOUND:53477758

object_name: headache disorder


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C5227439

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Wound Infection


subject: PUBCHEM.COMPOUND:23724878

object_name: Wound Infection, CTCAE


subject: PUBCHEM.COMPOUND:23724878

object_name: Surgical Wound Infection


subject: PUBCHEM.COMPOUND:23724878

object_name: cellulitis


subject: PUBCHEM.COMPOUND:23724878

object_name: cellulitis on exam (physical finding)


subject: PUBCHEM.COMPOUND:23724878

object_name: abscess


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Executive dysfunction


subject: CHEBI:4466

object_name: post-traumatic stress disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6931

subject_name: Midazolam

object_name: Critical Illness


subject: CHEBI:6931


subject: CHEBI:6931

object_name: Sedation complication


subject: CHEBI:6931


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: lung cancer


subject: UMLS:C3827032

object_name: lung neoplasm


subject: UMLS:C3827032

object_name: carcinoma


subject: PUBCHEM.COMPOUND:22982613

object_name: neoplasm


subject: CHEBI:87620

subject_name: EPIESTRIOL

object_name: Genitourinary symptom


subject: CHEBI:87620

object_name: Postmenopausal symptoms


subject: CHEBI:87620

object_name: postmenopausal atrophic vaginitis


subject: CHEBI:27974

subject_name: Estriol


subject: CHEBI:27974


subject: CHEBI:27974


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: EXCESS LMW-DNA


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: squamous cell carcinoma of penis


subject: UNII:52CMI0WC3Y

object_name: kidney medullary carcinoma


subject: UNII:52CMI0WC3Y

object_name: collecting duct carcinoma


subject: UNII:52CMI0WC3Y

object_name: bladder squamous cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: urinary bladder small cell neuroendocrine carcinoma


subject: UNII:52CMI0WC3Y

object_name: squamous cell carcinoma of urinary organs


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:GT0I9SV4F6

subject_name: Mavoglurant

object_name: alcohol consumption (history)


subject: UNII:GT0I9SV4F6

object_name: Alcoholic Intoxication


subject: UNII:GT0I9SV4F6

object_name: alcohol dependence